Associated Papers
Advancements in the research of the structure, function, and disease-related roles of ARMC5.
Qu Y et al.
Frontiers of Medicine, 2025
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update.
Bouys L et al.
Orphanet Journal of Rare Diseases, 2025
Somatic Molecular Heterogeneity in Bilateral Macronodular Adrenocortical Disease (BMAD) Differs Among the Pathological Subgroups.
Violon F et al.
Endocrine Pathology, 2024
Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations.
Tang P et al.
Bmc Endocrine Disorders, 2023
Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients.
Bouys L et al.
European Journal of Endocrinology, 2022
Cullin 3 targets the tumor suppressor gene ARMC5 for ubiquitination and degradation.
Cavalcante IP et al.
Endocrine-related Cancer, 2020
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.
Albiger NM et al.
Endocrine, 2017
ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.
Espiard S et al.
The Journal of Clinical Endocrinology and Metabolism, 2015
ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.
Assié G et al.
The New England Journal of Medicine, 2013
Select a paper to view details